definit
receptor
ultim
depend
upon
structur
function
identif
site
specif
recogn
ligand
rigor
character
receptorligand
interact
deriv
present
address
inserm
hgpital
de
bicetr
bicetr
franc
bind
studi
radiolabel
ligand
neuropharmacolog
endocrinolog
difficult
studi
interact
viral
particl
cell
surfac
rigor
fashion
viral
particl
sever
order
magnitud
larger
convent
ligand
make
imposs
perform
mani
manipul
routin
done
hormon
exampl
addit
virus
contain
repeat
subunit
mani
copi
viral
attach
protein
present
virion
surfac
thu
singl
virion
may
interact
mani
receptor
site
cell
surfac
nonetheless
principl
receptorligand
interact
establish
ligand
appli
virus
well
establish
framework
definit
viral
receptor
simplest
level
viral
receptor
structur
membran
surfac
cell
viru
bind
prior
enter
cell
often
presenc
absenc
viral
receptor
determin
whether
cell
infect
viru
also
possibl
structur
cell
surfac
viru
bind
serv
conduit
viral
entri
cell
viral
bind
site
could
import
biolog
consequ
affect
cell
function
trigger
surfac
structur
affect
cellular
metabol
improt
gener
immun
respons
viru
broadest
sens
viral
receptor
structur
cell
surfac
viru
bind
bind
biolog
import
measur
biolog
relev
way
definit
viral
recognit
site
receptor
involv
three
major
criteria
deriv
model
ligandreceptor
interact
bennet
includ
satur
specif
competit
saturnbiliq
viru
interact
cell
surfac
discret
site
along
membran
finit
number
site
avail
viral
bind
high
concentr
viru
abl
fulli
occupi
satur
therefor
possibl
increas
concentr
particl
present
cell
surfac
bind
result
shown
experiment
determin
viral
bind
function
increas
viral
concentr
satur
demonstr
plot
result
hyperbol
curv
see
fig
ia
specif
specif
first
demonstr
accord
biolog
paramet
word
viral
bind
observ
cell
viru
infect
cell
viral
bind
induc
biolog
measur
respons
second
measur
specif
relat
bind
assay
even
viru
bind
biolog
relev
cell
certain
proport
viral
bind
nonspecif
unrel
specif
viral
receptor
exampl
electrostat
forc
result
nonspecif
adher
particl
cell
surfac
nonspecif
bind
contain
bind
curv
nonspecif
compon
usual
satur
therefor
bind
reoviru
type
lcell
fibroblast
point
repres
arithmet
mean
three
separ
determin
uptak
cellsisampl
equilibr
minut
linear
nonspecif
bind
determin
mix
concentr
label
viru
equal
volum
high
titer
unlabel
viru
contain
x
particlesiml
satur
bind
curv
result
subtract
linear
compon
total
bind
curv
maximum
uptak
uptak
valu
satur
kd
viru
concentr
half
satur
point
scatchard
plot
reoviru
bound
l
cell
subtract
linear
compon
boundifre
calcul
divid
correct
cpm
viral
concentr
express
particl
divid
avogadro
number
result
molar
express
linear
regress
analysi
data
provid
slope
estim
k
linear
function
measur
subsequ
subtract
total
bind
reveal
specif
bind
fig
competit
possibl
competit
inhibit
specif
bind
use
second
ligand
known
bind
receptor
neuropharmacolog
exampl
specif
bind
acetylcholin
muscarin
acetylcholin
receptor
defin
compon
total
bind
block
atropin
viral
system
specif
blocker
type
usual
unavail
certain
method
competit
block
bind
radiolabel
viru
unlabel
viru
possibl
viral
attach
protein
varieti
nomenclatur
use
describ
viralreceptor
interact
depend
context
discuss
sever
abbrevi
use
articl
protein
viru
attach
cell
viral
attach
protein
vap
receptor
surfac
cell
viru
bind
cellular
receptor
site
cr
final
postul
cr
may
compos
multipl
unit
unit
may
bind
singl
vap
term
cellular
receptor
unit
cru
lonbergholm
varieti
approach
use
studi
interact
viral
particl
cell
surfac
receptor
recept
site
describ
approach
advantag
limit
rigor
studi
viralreceptor
interact
requir
use
one
techniqu
sinc
differ
approach
provid
complementari
inform
viral
bind
assay
measur
number
infecti
viral
particl
either
remain
medium
follow
viral
bind
cell
attach
cell
attach
viru
may
detect
measur
infect
cell
infecti
center
dissoci
receptor
bound
infecti
viru
provid
receptormedi
cellmedi
modif
eclips
viru
particl
prevent
account
advantag
infect
assay
bind
small
amount
viru
detect
viral
replic
biolog
function
measur
infect
assay
follow
limit
bind
infecti
viral
particl
measur
viral
prepar
particl
plaqueform
unit
pfu
ratio
like
noninfecti
viru
also
bind
cellular
receptor
site
measur
infecti
particl
plaqu
assay
time
consum
cumbersom
statist
errorpron
make
gener
quantit
data
difficult
infecti
center
measur
cell
bear
membran
receptor
unabl
support
viral
replic
detect
attach
cell
must
detect
measur
viru
remov
media
factor
modifi
penetr
replic
affect
result
sinc
data
reflect
end
product
infect
one
seri
experi
investig
surmount
limit
infect
assay
use
studi
receptordetermin
host
restrict
ecotrop
xenotrop
murin
leukemia
virus
approach
pseudotyp
virion
creat
contain
envelop
one
viru
infecti
genom
anoth
pseudotyp
virion
gener
mix
infect
vsv
cell
studi
permiss
variou
retrovirus
cell
permiss
result
virion
contain
vsv
envelop
inactiv
antivsv
neutral
antibodi
remain
pseudotyp
virion
retroviru
envelop
vsv
genom
bound
cell
surfac
receptor
retroviru
studi
result
vsv
replic
thu
vsv
replic
measur
presenc
surfac
receptor
retrovirus
varieti
host
cell
independ
abil
replic
viru
besmer
baltimor
hemagglutin
assay
depend
abil
mani
virus
agglutin
red
blood
cell
although
red
cell
receptor
respons
viral
hemagglutin
might
viral
receptor
host
cell
hemagglutin
provid
import
inform
virusreceptor
interact
note
hemagglutin
depend
upon
lattic
format
depend
upon
condit
eg
temperatur
thu
measur
attach
direct
studi
use
hemagglutin
detect
differ
neuraminidas
sensit
erythrocyt
receptor
variou
envelop
virus
exampl
erythrocyt
receptor
parainfluenza
viru
type
appear
neuraminidas
resist
receptor
influenza
viru
serotyp
b
hirst
inactiv
neuramininidas
adenoviru
type
bind
neuraminidasetr
erythrocyt
type
wadel
boulang
et
al
nonenvelop
virus
hemagglutin
total
resist
neuraminidas
eg
reoviru
gomato
tamm
modifi
version
hemagglutin
roset
techniqu
method
cell
test
ad
aliquot
chronic
infect
cell
cell
express
viral
receptor
adher
surfac
infect
cell
express
viral
attach
protein
vap
order
use
roset
techniqu
requir
suffici
number
vap
express
surfac
infect
cell
hemadsorpt
erythrocyt
cultur
virusinfect
cell
variat
roset
techniqu
method
rosett
form
erythrocty
viral
receptor
surfac
techniqu
viralinduc
agglutin
also
use
cell
erythrocyt
specif
lymphocyt
woodruff
woodruff
use
agglutin
lymphocyt
virus
defin
receptor
myxoand
paramyxovirus
cell
discuss
section
techniqu
also
allow
character
receptor
use
reagent
block
agglutin
eg
enzym
antibodi
bankhurst
et
al
fluoresceinor
rhodaminelabel
antivir
antibodi
use
visual
presenc
viru
bound
surfac
variou
cell
type
exampl
indirect
immunofluoresc
techniqu
use
defin
b
cell
lymphocyt
subset
suscept
ebv
infect
jondal
klein
major
advantag
measur
viru
bind
indirect
immunofluoresc
afford
qualit
approach
studi
viralreceptor
interact
especi
relev
studi
primari
cell
cultur
contain
mixtur
cell
type
exampl
studi
serotypespecif
bind
reoviru
cell
nervou
system
prepar
cell
suspens
mous
brain
contain
ciliat
ependym
cell
cell
easili
identifi
phase
microscopi
cilia
use
indirect
immunofluoresc
possibl
demonstr
reoviru
type
vivo
affin
ependym
cell
type
bind
cell
see
fig
b
discuss
detail
later
similarli
indirect
immunofluoresc
use
demonstr
reoviru
type
bind
subset
murin
human
lymphocyt
fig
weiner
et
al
cocap
studi
extens
indirect
immunofluoresc
approach
experi
take
advantag
properti
physiolog
activ
cell
modul
receptor
site
bound
ligand
one
pole
cell
fig
use
two
differ
color
fluorochrom
one
mark
bound
viru
label
anoth
cell
surfac
structur
possibl
determin
cell
surfac
compon
move
associ
viral
receptor
viral
receptor
modul
one
pole
cell
approach
demonstr
ebv
receptor
cultur
cell
close
associ
complement
receptor
yefenof
er
al
cocap
studi
also
demonstr
reoviru
receptor
murin
lymphocyt
distinct
surfac
antigen
fc
receptor
epstein
et
al
viral
particl
may
directli
fluorescein
rhodamin
mcgrath
colleagu
use
direct
fluoresc
techniqu
studi
bind
mulv
virion
thymic
lymphoma
cell
mcgrath
et
al
mcgrath
weissman
studi
allow
quantit
well
qualit
measur
bind
sinc
amount
fluorochrom
per
viral
particl
could
compar
total
fluoresc
per
cell
measur
fluoresc
activ
cell
sorter
fac
extens
qualit
approach
describ
possibl
use
viru
select
heterogen
popul
cell
bind
viru
exampl
cell
bound
viru
label
fluorescein
antivir
antibodi
sort
fac
anoth
method
use
plateadher
develop
plateadher
techniqu
studi
reovirusreceptor
interact
techniqu
cell
first
incub
viru
rabbit
antivir
antibodi
cell
plate
petri
dish
previous
coat
goatantirabbit
immunoglobulin
separ
adher
nonadher
popul
use
plateadher
techniqu
percentag
reoviru
type
murin
splenic
lymphocyt
enrich
initi
unsepar
popul
plateadher
popul
epstein
et
al
radiolabel
virion
permit
quantit
measur
viral
bind
either
measur
loss
radioact
media
usual
measur
attach
label
viru
cell
impur
label
prepar
ie
label
particl
bind
two
approach
ident
richter
uptak
label
viru
cell
prefer
direct
approach
furthermor
measur
uptak
accur
exampl
uptak
accur
measur
loss
medium
radiolabel
studi
mani
investig
grown
viru
presenc
amino
acid
lonbergholm
lonbergholm
whiteley
fri
heleniu
prepar
specif
activ
rang
viral
particl
lonbergholm
use
studi
time
cours
viralreceptor
interact
competit
receptor
differ
virus
physic
condit
affect
viral
bind
ionic
strength
ph
temperatur
cell
concentr
also
studi
lonbergholm
whiteley
philipson
lactoperoxidasecatalyz
iodin
label
viral
surfac
compon
contain
tyrosin
residu
marchaloni
et
al
although
like
result
prepar
contain
inactiv
virion
k
lonbergholm
b
korant
person
commun
epstein
et
al
unpublish
data
iodin
viru
yield
label
viru
higher
specif
activ
reoviru
possibl
obtain
specif
activ
approxim
particledyci
gener
greater
specif
activ
ligand
accur
quantit
measur
made
radiolabel
purifi
viral
attach
protein
ie
retroviru
spike
glycoprotein
adenoviru
fiber
also
use
studi
bind
cellular
receptor
delarco
todaro
choppin
et
al
final
protein
use
indirect
studi
surfac
interact
mous
mammari
tumor
virus
mous
rat
cell
viru
bound
cell
surfac
detect
use
monoclonalantivir
antibodi
bound
label
protein
altrock
et
f
interact
viral
particl
receptor
depend
upon
number
physic
condit
includ
receptor
affin
densiti
viral
concentr
temperatur
ph
ionic
strength
bath
medium
use
studi
bind
interact
use
standard
valu
variabl
vari
one
paramet
time
mathemat
model
receptor
interact
deriv
equat
enzym
kinet
develop
micha
menten
lehning
approach
assum
revers
bimolecular
bind
repres
eq
l
condit
necessarili
true
viral
bind
receptor
one
approach
found
use
character
interact
reoviru
particl
ligand
l
receptor
site
r
cell
studi
bind
equilibrium
condit
simpl
revers
bimolecular
reaction
hold
r
l
repres
viral
particl
bound
receptor
receptorligand
complex
k
k
repres
forward
associ
backward
dissoci
rate
constant
viru
bind
receptor
equilibrium
dissoci
constant
reaction
k
describ
rel
concentr
reagent
equilibrium
ratio
rate
constant
repres
equat
squar
bracket
repres
concentr
bind
interact
concentr
r
unknown
cell
number
rather
number
site
manipul
experi
cell
number
held
constant
experi
viral
concentr
vari
uptak
curv
viru
bind
receptor
may
obtain
see
fig
satur
hyperbol
bind
curv
fig
deriv
eq
eq
indic
total
number
receptor
rtota
sum
free
r
plu
bound
rl
receptor
small
amount
free
ligand
remov
solut
usual
l
approxim
equal
ltotal
otherwis
free
ligand
concentr
must
measur
directli
equilibrium
dissoci
associ
rate
constant
bind
k
k
also
estim
directli
measur
cellassoci
viru
function
time
rate
equat
fork
k
eq
result
plot
straight
line
x
intercept
maximum
bind
ligand
satur
r
slope
neg
reciproc
k
concern
howev
manipul
data
scatchard
analysi
propag
error
uptak
measur
x
axi
chang
rel
weight
variou
region
bind
curv
sinc
measur
viral
bind
alreadi
signific
uncertainti
magnif
error
reduc
accuraci
bind
data
although
use
extens
analyz
ligand
interact
neuropharmacolog
endocrinolog
scatchard
plot
use
viral
receptor
field
see
incardona
nonetheless
quantit
viral
bind
data
express
use
scatchard
analysi
see
fig
estim
densiti
cell
membran
receptor
site
certain
virus
use
either
growth
assay
radiolabel
bind
techniqu
despit
varieti
differ
cell
type
virus
use
estim
remark
consist
valu
rang
lo
site
per
cell
instanc
lonbergholm
philipson
estim
x
receptor
site
polioviru
hela
cell
found
similar
valu
adenoviru
virion
enterovirus
sever
differ
permiss
cell
line
similarli
birdwel
strauss
arriv
estim
site
per
cell
bind
sindbi
viru
recent
studi
laboratori
use
reovirion
provid
estim
rang
reoviru
type
receptor
site
lcell
fibroblast
reoviru
type
receptor
murin
lymphocyt
epstein
et
al
unpublish
mcclintock
et
af
arriv
slightli
higher
estim
x
lo
siteskel
emc
viru
bind
hela
cell
studi
use
purifi
subvir
bind
compon
eg
fiber
protein
adenoviru
usual
led
higher
estim
receptor
densiti
studi
use
whole
virion
exampl
lonbergholm
philipson
demonstr
log
increas
receptor
site
densiti
purifi
adenoviru
fiber
use
place
virion
lo
site
per
cell
similarli
x
lo
site
per
cell
estim
delarco
todaro
studi
bind
bind
glycoprotein
rauscher
murin
leukemia
viru
cell
studi
support
concept
viral
receptor
site
consist
multipl
receptor
unit
bind
individu
viral
attach
protein
virus
bind
cell
surfac
multival
fashion
studi
quantit
measur
affin
viral
bind
receptor
term
kd
equilibrium
bind
reaction
see
section
b
howev
long
assum
viruscel
interact
high
affin
rapid
time
cours
viral
bind
difficulti
disrupt
bound
viru
physic
mean
lonbergholm
philipson
although
suggest
certain
case
viral
bind
virtual
irrevers
dissoci
bound
viru
probabl
occur
interact
lonbergholm
rapid
penetr
bind
one
reason
dissoci
difficult
measur
initi
studi
laboratori
estim
low
kd
valu
reoviru
bind
l
cell
lymphocyt
demonstr
extrem
highaffin
bind
site
reoviru
epstein
et
al
unpublish
data
unlik
structur
cell
surfac
serv
viral
receptor
evolv
mere
purpos
viru
bind
viral
receptor
probabl
serv
biolog
function
cell
known
exampl
bacteriophag
receptor
compon
transport
system
lowmolecularweight
sugar
hazelbau
influenza
viru
receptor
erythrocyt
extens
character
kathan
et
al
sialoglycoprotein
call
glycophorin
multipl
function
includ
n
blood
group
activ
springer
et
al
lectin
bind
activ
jackson
et
al
extens
biochem
character
purif
receptor
see
bur
review
analog
studi
type
cell
confirm
sialic
acidcontain
glycoprotein
import
structur
featur
myxoand
paramyxoviru
recept
site
receptor
protein
rausher
mulv
previous
describ
vap
appear
lipoprotein
sinc
bind
activ
fibroblast
membran
destroy
proteindenatur
agent
treatment
chymotrypsin
phospholipas
kalyanaraman
et
al
mcgrath
et
al
suggest
tlymphoma
cell
surfac
receptor
mulv
might
ident
cell
antigenbind
receptor
howev
recent
isol
dalton
dimer
protein
thymocyt
retain
maloney
mulv
bind
activ
differ
size
previous
report
valu
tcell
idiotyp
receptor
binz
wigzel
schaffardeshay
et
al
also
differ
frcm
immunoglobulin
fc
receptor
also
suggest
candid
mulv
receptor
studi
cocap
experi
shown
relationship
though
ident
ebv
receptor
receptor
complement
compon
yefenof
et
al
heleniu
et
al
report
solubil
receptor
semliki
forest
viru
sfv
enrich
hla
antigen
subsequ
studi
oldston
et
al
show
bind
growth
sfv
cell
lack
hla
antigen
indic
hla
antigen
biolog
receptor
sfv
bind
recent
acetylcholin
receptor
achr
propos
function
rabi
viru
receptor
mous
muscl
cell
conclus
base
similar
anatom
distribut
bound
viru
acetylcholin
antagonist
observ
fluoresc
microscopi
addit
block
studi
show
pretreat
cell
achr
blocker
abungarotoxin
dtubocurarin
decreas
viral
replic
suscept
cell
lentz
et
al
possibl
one
surfac
structur
might
function
viral
receptor
special
differ
circumst
daughaday
et
studi
dengu
viru
bind
human
macrophag
found
although
viral
receptor
destroy
trypsin
addit
specif
nonneutr
antibodi
allow
penetr
replic
viru
cell
postul
fc
receptor
serv
nonneutr
viral
receptor
instanc
allow
bind
nonneutr
viralantivir
antibodi
complex
cell
via
fc
portion
immunoglobulin
molecul
attach
viru
monoclon
antibodi
direct
viral
receptor
repres
new
approach
character
viral
cellular
receptor
site
fine
specif
monoclon
antibodi
permit
elucid
precis
cell
surfac
antigen
domain
involv
viral
bind
although
minim
data
use
approach
current
avail
time
review
technic
option
difficulti
associ
approach
one
avenu
screen
panel
monoclon
antibodi
rais
entir
cell
membran
hope
isol
one
specif
viral
receptor
antibodi
could
screen
base
upon
abil
inhibit
viral
bind
viral
growth
hemagglutin
attempt
approach
reoviru
order
find
antibodi
specif
reoviru
type
receptor
lymphocyt
larg
panel
monoclon
antibodi
murin
lymphocyt
produc
springer
colleagu
springer
test
abil
bind
lymphocyt
enrich
bear
reoviru
type
receptor
see
section
monoclon
antibodi
show
significantli
bind
viral
receptorposit
lymphocyt
test
abil
inhibit
bind
label
reoviru
type
lymphocyt
one
antibodi
found
effect
minim
reduc
viral
bind
analog
approach
campel
cord
gener
monoclon
antibodi
hela
cell
identifi
monoclon
antibodi
block
bind
coxsackieviru
polioviru
hela
cell
second
approach
use
take
advantag
natur
regul
immun
respons
idiotypeantiidiotyp
network
explain
network
might
function
normal
immun
respons
viru
assum
viru
one
antigen
determin
determin
bind
b
lymphocyt
appropri
receptor
idiotyp
cell
surfac
antivir
antibodi
produc
b
lymphocyt
bear
idiotyp
determin
bind
viru
idiotyp
determin
immunogen
serv
antigen
antiidiotyp
antibodi
made
antiidiotyp
antibodi
bind
viru
may
bind
cell
surfac
structur
origin
bound
viru
thu
theori
could
use
specif
antireceptor
antibodi
approach
first
use
endocrinolog
antiidiotyp
antibodi
rais
antibodi
retinol
bind
protein
insulin
antiidiotyp
antibodi
shown
recogn
cell
surfac
receptor
either
retinol
bind
protein
insulin
furthermor
found
antiidiotyp
antibodi
made
insulin
antibodi
mimick
biolog
effect
insulin
adipocyt
sege
peterson
attempt
similar
approach
obtain
antibodi
reoviru
type
receptor
experi
polyclon
xenogen
antiidiotyp
antiserum
made
inject
rabbit
hemagglutininspecif
mous
antireoviru
type
antibodi
viral
hemagglutinin
reoviru
vap
nepom
et
af
antiidiotyp
antiserum
absorb
normal
mous
immunoglobulin
purifi
use
monoclon
antibodi
neutral
site
hemagglutinin
reoviru
type
purifi
antiidiotyp
antibodi
mimick
viru
bind
pattern
variou
cell
line
moreov
bound
primari
cultur
murin
neuron
cell
bind
reoviru
type
bind
freshli
prepar
ependym
cell
bind
reoviru
type
type
addit
appear
mimic
viru
interact
murin
lymphocyt
see
section
v
nepom
et
al
prepar
tardieu
et
al
thu
appear
antiidiotyp
antibodi
might
recogn
cr
reoviru
type
neuron
lymphocyt
work
progress
character
properti
antiidiotyp
antibodi
term
block
viral
growth
determin
structur
cell
surfac
recogn
use
similar
approach
mcgrath
weissman
studi
spontan
murin
b
cell
lymphoma
bcll
recent
produc
monoclon
antiidiotyp
antibodi
bclligm
bind
bcll
associ
retroviru
demonstr
monoclon
antiidiotyp
antibodi
block
bind
retroviru
bcll
cell
mcgrath
l
weissman
person
commun
instanc
structur
plasma
membran
serv
viral
receptor
specif
singl
viru
instanc
differ
virus
may
share
receptor
concept
viral
receptor
famili
introduc
lonbergholm
et
al
experi
abl
block
bind
one
viru
cell
surfac
preincub
cell
unrel
viru
see
boulang
philipson
review
bind
measur
either
infect
use
uvinactiv
viru
block
radiolabel
viru
use
unlabel
viru
block
immunofluoresc
use
specif
antivir
antibodi
recogn
block
viru
studi
establish
hela
cell
receptor
varieti
picornavirus
virus
share
common
receptor
thu
three
polioviru
serotyp
compet
common
receptor
distinct
receptor
bind
six
group
coxsacki
b
virus
crowel
crowel
coxsacki
virus
distinct
receptor
two
group
echovirus
human
rhinovirus
separ
receptor
picomavirus
crowel
siak
moreov
receptor
shown
share
virus
differ
group
thu
bind
adenoviru
type
hela
cell
block
coxsacki
bind
human
rhinoviru
type
block
coxsacki
viru
lonbergholm
ef
al
confirm
receptor
famili
defin
experi
ultim
depend
upon
biochem
character
viral
receptor
site
serotyp
specif
virus
also
associ
serotyp
differ
receptor
exampl
two
serotyp
reoviru
type
differ
abil
bind
primari
cell
cultur
reoviru
type
bind
neuron
lymphocyt
wherea
reoviru
type
bind
ependym
cell
see
addit
bind
experi
use
virion
suggest
differ
bind
pattern
two
reoviru
serotyp
l
cell
even
though
serotyp
bind
grow
continu
cell
line
epstein
ef
al
unpublish
specif
receptor
two
serotyp
herp
simplex
viru
also
describ
vahln
et
al
experi
herp
simplex
type
hsv
interf
adsorpt
hsv
human
monkey
rabbit
perman
cell
line
adsorpt
rate
measur
assay
infect
viru
remain
medium
measur
cell
associ
thymidinelabel
hsv
adsorpt
profil
demonstr
monkey
kidney
cell
line
rabbit
cornea
cell
line
hsvl
receptor
hela
cell
express
receptor
affin
type
type
human
embryon
lung
cell
cell
line
deriv
human
carcinoma
larynx
show
equal
amount
hsv
receptor
experi
demonstr
hsv
bind
significantli
murin
ependym
cell
viral
interfer
assay
use
studi
specif
cell
surfac
receptor
retrovirus
steck
rubin
first
demonstr
retrovir
interfer
show
chicken
fibroblast
persist
infect
avian
retroviru
suscept
superinfect
viru
rubin
rubin
later
studi
establish
interfer
result
blockad
viral
receptor
endogen
produc
virus
review
weiss
similar
approach
use
studi
anoth
group
retrovirus
murin
leukemia
virus
murin
leukemia
virus
mulv
classifi
ecotrop
xenotrop
amphotrop
depend
abil
infect
mous
cell
cell
speci
cell
mice
speci
respect
use
crossinterfer
approach
shown
cell
infect
one
ecotrop
viru
fail
bind
second
ecotrop
strain
rmulv
wherea
cell
infect
xenotrop
viru
bound
rmulv
well
uninfect
cell
hartley
row
besmer
baltimor
thu
murin
ecotrop
xenotrop
virus
appear
recogn
differ
receptor
murin
cell
surfac
variou
strain
ecotrop
mulv
util
receptor
sinc
subject
crossinterfer
sarma
et
al
delarco
todaro
subsequ
show
infect
murin
cell
variou
ecotrop
virus
akr
rmulv
mmulv
prevent
bind
radiolabel
rmulv
vap
rmulv
surfac
infect
cell
interfer
studi
use
purifi
demonstr
ecotrop
virus
use
famili
receptor
despit
mark
differ
antigen
properti
virus
confirm
murin
xenotrop
well
amphotrop
virus
use
differ
famili
receptor
murin
ecotrop
virus
sinc
interfer
viral
infect
bind
similarli
class
mous
mammari
tumor
virus
mmtv
share
antigen
similar
surfac
glycoprotein
vap
mmtv
gr
mmtv
recogn
common
cell
surfac
receptor
differ
surfac
receptor
recogn
mmtv
antigen
differ
mmtv
riii
mmtv
altrock
et
al
schochetman
et
al
experi
viral
bind
studi
measur
bind
protein
immun
complex
compos
mmtv
typespecif
monoclon
antibodi
receptor
bound
mmtv
directli
measur
radiolabel
mmtv
bind
cell
virus
share
classspecif
determin
also
share
common
surfac
antigen
receptor
involv
viru
adsorpt
final
vap
typec
type
primat
retrovirus
recogn
receptor
moldow
et
al
find
might
reflect
relationship
typec
type
vap
suggest
immunolog
crossreact
stephenson
et
al
devar
er
al
studi
perform
use
continu
cell
line
import
howev
also
studi
viral
bind
cell
may
target
viral
infect
vivo
approach
easili
implement
use
freshli
isol
lymphocyt
studi
virusreceptor
interact
lymphocyt
subpopul
exampl
epsteinban
viru
select
bind
human
b
lymphocyt
mous
adapt
cytomegaloviru
bind
murin
b
lymphocyt
measl
murin
leukemia
viru
bind
human
lymphocyt
greav
woodruff
woodruff
done
varieti
studi
bind
myxovirus
paramyxovirus
murin
lymphocyt
found
sendai
viru
newcastl
diseas
viru
ndv
influenza
b
viru
influenza
viru
agglutin
lymphocyt
v
presum
lymphocyt
receptor
virus
receptor
lymphocyt
paramyxovirus
studi
sendai
ndv
differ
myxovirus
influenza
shown
differ
bind
group
virus
accord
temperatur
vitro
treatment
fetuin
nacetyl
neuramin
acid
period
addit
elut
ndv
lymphocyt
lymphocyt
agglutin
influenza
viru
ndv
sendai
viru
nine
serotyp
influenza
viru
studi
also
demonstr
differ
abil
bind
b
cell
five
strain
agglutin
b
cell
wherea
four
agglutin
b
lymphocyt
thu
lymphocyt
receptor
distinguish
among
variou
serotyp
influenza
viru
use
indirect
immunofluoresc
techniqu
found
receptor
reoviru
type
murin
human
lymphocyt
wherea
minim
bind
visual
reoviru
type
weiner
et
al
studi
recent
extend
quantit
studi
use
virion
show
satur
bind
reoviru
type
lymphocyt
minim
bind
reoviru
type
satur
compon
epstein
et
al
prepar
thu
lymphocyt
differ
receptor
reoviru
serotyp
receptor
reoviru
suffici
high
affin
bind
character
recent
v
affin
mous
hepat
viru
macrophag
lymphocyt
natur
resist
suscept
mice
shown
ident
krystyniak
dupuy
addit
encephalomyocard
viru
bound
resid
periton
macrophag
contrast
unstimul
splenic
lymphocyt
detect
number
emc
viru
receptor
receptor
could
induc
b
lymphocyt
mitogen
stimul
morishima
et
al
addit
lymphocyt
macrophag
cell
biolog
interest
studi
particular
interest
viral
receptor
nervou
system
tissu
techniqu
exist
obtain
freshli
isol
cell
central
nervou
system
oligodendrocyt
snyder
et
astrocyt
farooq
norton
ependym
cell
manthorp
et
al
instanc
neuron
farooq
norton
freshli
isol
cell
use
identifi
virus
affin
initi
approach
studi
viral
receptor
freshli
isol
human
murin
cell
experi
viral
bind
ependym
cell
demonstr
indirect
immunofluoresc
use
specif
antivir
antiserum
reoviru
type
induc
hydrocephalu
mice
bound
surfac
isol
human
murin
ciliat
ependym
cell
wherea
reoviru
type
induc
hydrocephalu
vivo
bind
properti
reoviru
type
ependym
cell
map
viral
hemagglutinin
vap
use
singleseg
recombin
clone
reoviru
clone
contain
nine
gene
reoviru
type
one
gene
encod
viral
hemagglutinin
type
bound
ependym
cell
wherea
reciproc
clone
addit
mump
viru
measl
viru
parainfluenza
type
herp
simplex
viru
type
bound
murin
ependym
cell
wherea
herp
simplex
viru
type
polioviru
type
work
cn
viral
receptor
mclaren
holland
describ
later
articl
thu
demonstr
unrel
virus
may
share
common
receptor
cell
surfac
virus
vap
usual
bind
receptor
even
part
viru
differ
retrovirus
recombin
clone
reovirus
hand
differ
serotyp
viru
may
poliovirus
coxsacki
virus
may
share
reovirus
herp
simplex
virus
influenza
virus
common
cell
surfac
receptor
viru
bind
differ
cell
use
ident
differ
cell
receptor
site
issu
particularli
relev
sinc
studi
viral
bind
util
perman
cell
line
known
extent
homolog
surfac
receptor
differ
cell
line
viru
bind
importantli
whether
result
obtain
bind
studi
use
transform
cell
gener
vivo
virussurfac
receptor
interact
earli
investig
suggest
differ
structur
serv
viral
receptor
differ
cell
line
kodza
junglebut
sabin
holland
mclarren
one
experiment
approach
address
issu
compar
two
differ
permiss
cell
line
variabl
number
receptor
per
cell
affin
receptor
viru
suscept
receptor
inactiv
agent
proteolyt
enzym
exampl
sindbi
viru
replic
mammalian
mosquito
cell
line
smith
tignor
studi
attach
two
sindbi
viru
strain
avirul
neurovirul
cell
line
enzym
treatment
cell
mammalian
cellular
receptor
avirul
strain
sensit
proteolyt
cleavag
mosquito
cell
insensit
proteas
phospholipas
neuraminidas
differ
less
strike
still
present
neurovirul
strain
reoviru
type
bind
freshli
isol
lymphocyt
l
cell
murin
fibroblast
cell
line
although
bind
studi
use
viru
suggest
similar
receptor
two
type
cell
xenogen
antiidiotyp
antibodi
rais
hemagglutininspecif
antireoviru
type
antibodi
see
section
iii
c
bind
lymphocyt
subpopul
reoviru
type
bind
l
cell
nepom
et
al
prepar
tardieu
et
al
assum
antiidiotyp
antibodi
recogn
cr
reoviru
type
lymphocyt
neuron
would
appear
receptor
site
lymphocyt
neuron
express
antigen
determin
absent
receptor
site
l
cell
analog
approach
attach
kinet
radiolabel
encephalomyocard
viru
compar
establish
murin
human
cell
line
mcclintock
et
l
receptor
viru
human
cell
higher
affin
viru
murin
cell
addit
attach
viru
hela
cell
temperatureindepend
rang
wherea
attach
murin
cell
progress
decreas
increas
temperatur
associ
increas
rate
dissoci
viru
thu
three
model
appear
may
structur
differ
receptor
site
given
viru
variou
cell
definit
answer
issu
requir
isol
character
cru
particular
viru
determin
compon
receptor
viru
bind
attach
viru
cellular
receptor
site
first
step
seri
event
intern
uncoat
replic
assembl
ultim
result
viral
replic
presenc
specif
receptor
cell
surfac
necessari
suffici
condit
viral
replic
thu
nonpermiss
cell
import
question
whether
restrict
occur
receptor
intracellular
level
vitro
ebv
infect
occur
human
primat
lymphocyt
ebv
receptor
present
b
lymphocyt
jondal
klein
greav
determin
hostrang
restrict
ebv
growth
receptormedi
ebv
receptor
purifi
raji
cell
membran
transfer
membran
murin
lymphocyt
cell
human
cell
line
nonpermiss
viru
volski
et
al
transfer
accomplish
use
vesicl
reconstitut
mixtur
purifi
raji
membran
sendai
viru
envelop
protein
success
implant
receptorrich
membran
membran
nonpermiss
cell
demonstr
monitor
fate
radioiodin
donor
membran
confirm
detect
surfac
ebv
receptor
complement
receptor
close
associ
ebv
receptor
yefenof
et
al
implant
cell
ebv
receptor
could
detect
hour
implant
radiolabel
ebv
bound
specif
receptorimpl
cell
furthermor
implant
receptor
biolog
function
sinc
viru
penetr
replic
demonstr
normal
resist
cell
measur
expresss
ebv
earli
nuclear
antigen
ebv
capsid
antigen
replic
viru
occur
cell
lack
appropri
viral
receptor
barrier
infect
cell
surfac
circumv
achiev
polioviru
two
method
direct
inocul
viral
nucleic
acid
cytoplasm
cell
lack
polioviru
receptor
physic
entrap
viru
cell
fusion
cellular
membran
sendai
viru
incorpor
poliovirus
bound
nonspecif
cell
surfac
viruscontain
liposom
ender
et
al
wilson
et
al
mani
studi
demonstr
import
sialic
acid
bind
polyoma
sendai
viru
myxoand
paramyxovirus
cell
surfac
sialidas
treatment
host
cell
prevent
viral
infect
virus
hirst
klenk
et
al
cellular
receptor
identifi
glycoprotein
nacetyl
neuramin
acid
termin
sugar
carbohydr
side
chain
gottshalk
elucid
role
sialic
acid
cell
permiss
bind
viru
isol
highli
purifi
gangliosid
defin
structur
studi
svennerholm
fredman
initi
bind
polystyren
petri
dish
coat
differ
gangliosid
studi
holmgren
et
al
host
cell
made
resist
sendai
viru
remov
endogen
viral
receptor
vibrio
cholera
sialidas
markwel
paulson
receptorneg
cell
incub
individu
purifi
gangliosid
incub
cell
gangliosid
contain
sequenc
galpl
fulli
restor
suscept
sendai
viru
infect
furthermor
incub
gangliosid
sequenc
end
two
sialic
acid
linkag
rather
singl
sialic
acid
time
effect
markwel
et
al
analog
way
suscept
polyoma
viru
infect
restor
implant
sequenc
sequenc
even
though
latter
sequenc
contain
compar
amount
sialic
acid
fri
et
al
thu
sendai
polyoma
viru
interact
specif
gangliosid
sequenc
cell
suscept
infect
modifi
implant
differ
gangliosid
cell
membran
attach
enterovirus
hela
cell
inhibit
heterolog
antiserum
rais
hela
cell
suggest
antibodi
way
affect
cell
surfac
viral
receptor
quersinthiri
axler
crowel
much
zajac
approach
limit
howev
lack
fine
specif
antiserum
monoclon
antibodi
direct
cell
surfac
offer
specif
avenu
gener
antireceptor
antibodi
recent
work
show
block
coxsacki
viru
bind
hela
cell
monoclon
antibodi
demonstr
feasibl
approach
campel
cord
similar
approach
recent
describ
monoclon
antibodi
made
thyrotropin
receptor
monoclon
antibodi
competit
block
bind
thyroid
stimul
hormon
tsh
unabl
stimul
adenyl
cyclas
activ
tsh
result
suggest
exist
second
domain
receptor
associ
stimul
activ
yavin
et
al
recent
shown
bind
insulin
alter
conform
insulin
receptor
fat
cell
pilch
czech
similar
question
rais
viral
receptor
viral
bind
cell
surfac
modifi
receptor
investig
relat
issu
follow
incub
human
lymphoblastoid
cell
epsteinbarr
viru
hinuma
et
al
ehrlich
ascit
tumor
cell
mengoviru
geschwend
traub
modul
cellsurfac
viral
receptor
cap
observ
occur
bind
viru
alon
investig
use
reoviru
cap
reoviru
type
receptor
surfac
murin
lymphocyt
requir
crosslink
antivir
antibodi
epstein
et
al
levanon
et
al
demonstr
adsorpt
infect
encephalomyocard
viru
enhanc
fluiditi
plasma
membran
bind
paramyxoand
orthomyxovirus
cell
surfac
result
destruct
receptor
hemagglutinin
paramyxovirus
bind
neuramin
acidcontain
cell
surfac
receptor
neuraminidas
activ
elimin
natur
neuramin
acidcontain
receptor
infect
cell
review
choppin
scheid
two
function
resid
two
separ
protein
orthomyxovirus
role
neuraminidas
activ
paradox
present
viral
protein
determin
viral
bind
unclear
recent
shown
two
oppos
activ
regul
environment
condit
chlorid
concentr
ph
high
concentr
halid
ion
enhanc
hemagglutin
activ
decreas
elut
erythrocyt
inhibit
neuraminidas
activ
merz
et
al
studi
specif
chemic
inhibitor
neuraminidas
pales
et
al
pales
compan
temperaturesensit
mutant
pales
et
al
suggest
role
neuraminidas
activ
releas
newli
synthes
viru
enhanc
low
chlorid
ion
concentr
acid
ph
neuraminidas
activ
promin
express
intracellularli
contrast
ionic
environ
extracellular
fluid
favor
viru
attach
receptordestroy
activ
age
depend
suscept
viral
infect
relev
question
role
receptor
nonpermiss
cell
sever
instanc
cell
adult
anim
permiss
viral
replic
cell
newborn
anim
even
though
appear
appropri
viral
receptor
exampl
allanto
sac
cell
young
chicken
embryo
permiss
influenza
vesicular
stomat
virus
cell
older
embryo
agedepend
differ
permiss
due
late
intracellular
event
sinc
viral
attach
penetr
cell
young
old
chicken
embryo
white
morahan
grossberg
investig
found
isol
newborn
adult
ependym
cell
receptor
reoviru
type
even
though
ependym
observ
promin
newborn
contrast
studi
coxsacki
infect
fibroblast
kunin
report
slightli
decreas
abil
absorb
viru
occur
adult
compar
newborn
cell
correl
decreas
permiss
adult
cell
viral
replic
instanc
agedepend
reduct
permiss
may
relat
chang
receptor
affin
viru
older
cell
case
genet
basi
express
viral
receptor
differ
cell
type
demonstr
exampl
cell
differ
mammalian
speci
differ
suscept
polioviru
ie
human
cell
suscept
murin
cell
somat
hybrid
made
permiss
human
resist
rodent
cell
belehradek
barski
wang
et
al
demonstr
hybrid
could
infect
polioviru
human
chromosom
present
miller
et
al
sinc
viral
replic
requir
presenc
human
gene
viral
nucleic
acid
enter
cell
wang
et
al
experi
demonstr
chromosom
carri
structur
gene
polioviru
receptor
hand
permiss
cell
virus
could
link
presenc
specif
human
chromosom
miller
et
al
genet
basi
specif
retroviru
cell
surfac
receptor
recent
review
weiss
util
interspeci
somat
cell
hybrid
techniqu
gene
encod
cr
ecotrop
mulv
murin
cell
assign
chromosom
oie
et
al
ruddl
et
af
marshal
rapp
gene
encod
cr
endogen
felin
ctype
viru
human
cell
assign
human
chromosom
schnitzer
et
al
note
howev
mulv
gene
express
chromosom
sole
regul
leukemia
viru
replic
anoth
gene
fvi
locat
murin
chromosom
regul
replic
viru
postpenetr
step
may
influenc
integr
provir
dna
host
chromosom
row
sato
gazdar
e
note
ruddl
et
addit
host
control
exert
level
differenti
sinc
bone
marrowderiv
thymusderiv
lymphocyt
abl
support
replic
exogen
mulv
genet
regul
receptor
express
therefor
one
part
genet
regul
cell
permiss
viru
identif
subvir
compon
respons
bind
virus
cell
surfac
preced
structur
understand
cellular
receptor
section
briefli
summar
current
data
concern
viral
attach
protein
vap
select
virus
picomavirus
small
nonenvelop
virus
icosahedr
symmetri
capsid
contain
copi
structur
unit
consist
four
separ
polypetid
vpi
picornavirus
contain
copi
precursor
protein
vpo
contain
uncleav
known
mani
year
shortli
polioviru
bind
cell
fraction
attach
viru
elut
halperen
et
elut
viru
lost
polypeptid
longer
infecti
lonbergholm
philipson
experi
suggest
attach
protein
studi
howev
provid
contradictori
evid
could
label
techniqu
label
surfac
protein
use
lactoperoxidas
eg
lonbergholm
butterworth
natur
occur
empti
capsid
top
compon
picornavirus
demonstr
ident
bind
characterist
nativ
viru
shown
lack
antibodi
recogn
surfac
nativ
virion
talbot
et
al
evid
suggest
vpl
bind
protein
express
surfac
capsid
trypsin
treatment
virion
render
incap
bind
cell
appear
primarili
cleav
vpi
although
studi
also
shown
cleavag
boulang
boulang
lonbergholm
coxsacki
viru
also
evid
present
capsid
surfac
philipson
el
ul
investig
suggest
singl
protein
function
viral
attach
site
cooper
interact
among
viral
protein
result
uniqu
conform
state
allow
bind
view
support
demonstr
differ
antigen
nativ
virion
antigen
inact
subvir
particl
c
antigen
sever
enterovirus
rhinovirus
nativ
particl
carri
antigen
determin
inact
particl
lonbergholm
yin
sinc
abil
attach
cell
irrevers
lost
convers
dto
cantigen
lonbergholm
yin
suggest
conform
capsid
polypeptid
may
play
key
role
abil
virion
attach
host
cell
perhap
regul
exposur
polypeptid
sequenc
carri
determin
requir
bind
activ
adenovirus
mammalian
avian
larger
complex
picornavirus
mammalian
virus
classifi
accord
speciesspecif
hemagglutin
properti
adenoviru
capsid
icosahedr
contain
capsom
call
hexon
neighbor
apic
capsom
surround
therefor
call
penton
consist
penton
base
project
call
fiber
fiber
consist
three
polypeptid
chain
shown
adenoviru
bind
cell
via
determin
locat
termin
knob
fiber
fiber
also
hemagglutinin
norrbi
et
al
abil
solubil
purifi
adenoviru
fiber
protein
led
demonstr
serotyp
differ
hemagglutinin
among
subgroup
adenovirus
reovirus
nonenvelop
virus
consist
two
concentr
icosahedr
capsid
shell
surround
segment
doublestrand
rna
genom
outer
capsid
compos
three
polypeptid
plc
al
individu
code
three
differ
viral
gene
polypeptid
make
outer
capsid
copi
per
virion
locat
vertic
icosahedr
structur
polypeptid
major
determin
reoviru
interact
cell
viral
hemagglutinin
elicit
format
neutral
antibodi
respons
develop
delay
type
hypersensit
gener
suppressor
cell
gener
cytolyt
lymphocyt
weiner
field
weiner
et
al
green
weiner
fontana
weiner
finberg
et
al
describ
previous
also
determin
serotyp
specif
viral
tropism
differ
cell
nervou
system
ultim
pattern
cn
virul
weiner
et
al
tardieu
weiner
tryptic
peptid
analysi
polypeptid
reoviru
serotyp
demonstr
uniqu
common
methionineand
tyrosinecontain
peptid
suggest
certain
region
hemagglutinin
conserv
other
drift
result
serotyp
chang
gentsch
field
monoclon
antibodi
prepar
viral
hemagglutinin
reoviru
type
defin
least
four
antigen
differ
domain
one
class
antibodi
neutral
activ
second
class
hemagglutin
inhibit
hi
activ
one
monoclon
antibodi
neutral
hi
activ
fourth
class
monoclon
antibodi
detect
neutral
hi
activ
result
suggest
mark
function
special
exist
within
region
reoviru
type
hemagglutinin
burstin
et
al
separ
region
hemagglutin
neutral
rais
possibl
virus
well
might
separ
viral
determin
bind
either
red
cell
hemagglutin
host
cell
infect
suggest
rbc
receptor
receptor
cell
type
may
homolog
paramyxovirus
two
glycoprotein
project
viral
surfac
isol
purifi
see
scheid
review
hn
glycoprotein
possess
hemagglutin
enzym
neuraminidas
activ
viral
receptorbind
protein
exist
surfac
dimer
configur
suggest
singl
activ
site
serv
function
remain
clarifi
scheid
et
al
f
glycoprotein
respons
fusion
activ
thu
hemolysi
involv
viru
penetr
cell
discuss
next
section
morbilii
virus
measl
canin
distemp
viru
lack
neuraminidas
bind
glycoprotein
design
h
rather
hn
three
serotyp
influenza
viru
compris
myxoviru
group
unlik
paramyxovirus
influenza
virion
contain
separ
spike
hemagglutinin
ha
present
trimer
neuraminidas
na
present
tetram
schild
influenza
c
virion
differ
neuraminidas
ha
glycoprotein
respons
hemagglutin
adsorpt
host
cell
antigen
variat
protein
larg
respons
period
epidem
influenza
monoclon
antibodi
rais
ha
influenza
identifi
three
four
nonoverlap
antigen
domain
protein
wiley
et
al
wilson
et
al
direct
correl
domain
function
differ
yet
defin
structur
definit
ha
provid
initi
answer
hostreceptor
bind
site
antigen
determin
locat
globular
region
lie
top
long
fibrou
coil
coil
fusion
activ
peptid
locat
near
viru
membran
end
molecul
laver
valentin
gerhard
et
al
wiley
et
al
wilson
et
al
viral
attach
protein
sever
retrovirus
isol
use
two
type
experi
crossinterfer
experi
discuss
section
iii
review
weiss
experi
defin
antigen
domain
molecul
monoclon
antibodi
latter
experi
perform
use
major
extern
glycoprotein
mous
mammari
tumor
viru
mmtv
two
topograph
distinct
site
identifi
one
site
function
target
neutral
antibodi
defin
observ
monoclon
antibodi
mab
neutral
viru
infect
also
compet
bind
neutral
mab
use
standard
second
site
bound
antibodi
bind
effect
neutral
site
topograph
distinct
mab
could
compet
bind
second
neutral
mab
massey
schochetman
shown
neutral
site
describ
receptor
bind
site
adjac
monoclon
antibodi
found
compet
bind
first
neutral
mab
neutral
viru
antibodi
function
block
antibodi
protect
viru
particl
neutral
massey
schochetman
b
two
glycoprotein
associ
envelop
strain
mous
hepat
viru
mhv
glycoprotein
make
peplom
viru
el
glycoprotein
deepli
embed
viral
membran
portion
el
glycoprotein
protrud
viral
membran
contain
small
glycosil
portion
holm
et
al
monospecif
antibodi
direct
glycoprotein
prevent
viral
attach
virion
lack
either
growth
presenc
tunicamycin
treatment
bromelain
attach
cell
membran
addit
isol
bind
receptor
intact
viru
sinc
pretreat
cell
unlabel
concentr
mhv
block
bind
raidolabel
thu
glycoprotein
appear
viru
attach
protein
strain
mhv
k
holm
person
commun
holm
et
al
major
featur
certain
viral
infect
select
damag
specif
tissu
instanc
specif
cell
within
tissu
classic
exampl
polioviru
infect
anterior
horn
cell
spinal
cord
exampl
includ
select
infect
limbic
system
rabi
viru
infect
ependym
cell
mump
viru
review
johnson
infect
pancreat
beta
cell
encephalomyocard
viru
coxsacki
viru
craighead
mclane
boucher
notkin
yoon
et
al
long
postul
vivo
tropism
virus
mediat
part
presenc
absenc
specif
receptor
site
virus
surfac
target
cell
holland
role
specif
cellular
receptor
determin
cell
tropism
extens
studi
recent
review
crowel
landau
initi
studi
picornavirus
use
organ
minc
homogen
demonstr
correl
presenc
receptor
cell
known
vivo
tropism
polioviru
human
monkey
cn
tissu
intestin
abl
adsorb
poliovirus
wherea
tissu
human
lung
heart
skin
correl
absolut
howev
sinc
receptor
also
detect
human
liver
monkey
heart
skelet
muscl
furthermor
polioviru
vaccin
strain
induc
cell
damag
shown
bind
brain
tissu
holland
kunin
jordan
laplaca
harter
choppin
second
line
evid
demonstr
relationship
cell
surfac
receptor
pathogen
presenc
correl
group
virus
receptor
specif
classif
accord
subgroup
deriv
pattern
pathogenesi
see
section
iii
c
lonbergholm
et
al
final
specif
organ
cultur
use
show
differ
growth
specif
picornavirus
exampl
rhinovirus
multipli
differenti
organ
cultur
trachea
hoorn
tyrel
coxsacki
virus
grow
differenti
primari
fetal
mous
muscl
cultur
grow
nondifferenti
mous
cultur
came
crowel
landau
et
al
contrast
receptor
human
enterovirus
exist
tissu
involv
pathogenesi
speci
natur
host
holland
kunin
jordan
laplaca
campbel
genet
approach
use
defin
molecular
basi
differ
pattern
virul
central
nervou
system
cell
tropism
exhibit
reoviru
serotyp
use
recombin
clone
deriv
cross
reoviru
type
shown
hemagglutinin
reoviru
encod
gene
determin
central
nervou
system
cell
tropism
reoviru
serotyp
weiner
et
al
reoviru
type
clone
contain
nine
gene
type
gene
encod
hemagglutinin
type
caus
fatal
enceph
newborn
mice
neuron
destruct
ependym
cell
damag
wherea
reoviru
type
clone
reciproc
clone
clone
caus
ependym
infect
without
neuron
damag
affin
two
serotyp
two
differ
cell
type
nervou
system
appear
due
specif
interact
viral
hemagglutinin
receptor
surfac
either
ependym
cell
neuron
cell
result
confirm
vitro
demonstr
reoviru
type
clone
reoviru
type
clone
bound
isol
human
murin
ependym
cell
fig
b
reciproc
result
shown
neural
cell
cultur
dichter
weiner
unpublish
data
see
fig
f
variant
encephalomyocard
viru
emc
produc
diabeteslik
syndrom
certain
strain
mice
infect
destroy
pancreat
beta
cell
cultur
pancreat
beta
cell
mice
resist
emcinduc
diabet
less
abl
absorb
infecti
emc
viru
beta
cell
suscept
strain
suggest
genet
determin
differ
surfac
viral
receptor
cell
may
one
factor
control
suscept
diseas
chairez
et
al
presenc
viru
receptor
lymphocyt
may
correl
specif
effect
virus
may
immun
respons
lymphocyt
receptor
measl
viru
measl
infect
associ
depress
tuberculin
skin
hypersensit
suppress
helper
cell
activ
mcfarland
reoviru
type
bind
primarili
subset
murin
lymphocyt
suppressorkytotox
subset
well
human
counterpart
cell
bind
properti
viral
hemagglutinin
epstein
et
al
furthermor
vitro
reoviru
type
induc
suppressor
cell
capabl
suppress
con
prolifer
fontana
weiner
gener
function
activ
suppressor
cell
vitro
reoviru
type
appear
secondari
interact
viral
hemagglutinin
specif
receptor
subset
murin
lymphocyt
specif
myxoand
paramyxovirus
particular
cell
type
depend
structur
function
activ
viral
surfac
glycoprotein
abil
cell
cleav
protein
review
choppin
scheid
interact
paramyxoviru
cell
surfac
mediat
two
glycoprotein
project
extern
surfac
virion
hemagglutininneuraminidas
hn
fusion
f
glycoprotein
bind
cellular
neuramin
acidcontain
receptor
properti
hn
glycoprotein
although
activ
differ
consider
accord
amount
posit
neuramin
acid
molecul
markwel
et
al
abund
sialic
acid
mani
biolog
membran
limit
import
bind
step
determin
cell
specif
tissu
tropism
activ
fusion
f
glycoprotein
howev
requisit
infect
celltocel
spread
infect
fusion
glycoprotein
act
viral
penetr
step
beyond
adsorpt
viru
infect
requir
cleavag
precursor
fo
glycoprotein
two
subunit
fl
host
must
provid
enzym
respons
cleavag
review
choppin
scheid
thu
hostdepend
cleavag
fo
requir
infect
therefor
host
rang
tissu
tropism
viru
determin
avail
appropri
proteas
choppin
recent
shown
neuraminidas
nanas
activ
hn
glycoprotein
mump
viru
contribut
cytopatholog
although
hn
glycoprotein
six
studi
strain
mump
viru
similar
size
antigen
composit
strain
possess
neuraminidas
distinct
enzymat
properti
strain
activ
nanas
caus
littl
cytopatholog
cell
fusion
african
green
kidney
cell
line
wherea
infect
strain
less
activ
nanas
caus
extens
cell
fusion
thu
viral
nanas
appear
contribut
full
express
activ
f
protein
ultim
cytopatholog
merz
wolinski
extend
previou
observ
influenza
virion
less
activ
nanas
caus
cytopatholog
tissu
cultur
pathogen
viva
virion
contain
activ
nanas
smith
cohen
choppin
choppin
tamm
moreov
strain
mump
viru
less
activ
nanas
neuroinvas
neurovirul
wolinski
stroop
mccarthi
et
af
thu
pathogen
myxoand
paramyxoviru
depend
upon
interact
viral
glycoprotein
cell
surfac
step
beyond
viral
adsorpt
cell
specif
determin
avail
proteas
surfac
cell
cleav
one
viral
glycoprotein
allow
viral
penetr
cell
data
concern
role
viral
receptor
interact
pathogen
envelop
virus
autiommun
reaction
host
tissu
report
certain
viral
infect
includ
product
autoantibodi
varieti
host
antigen
experiment
anim
man
dna
lymphocyt
myelin
review
onodera
et
af
man
welldocu
immunemedi
damag
peripher
nerv
myelin
infecti
polyneur
guillainbarr
syndrom
occur
week
viral
infect
follow
swine
flu
immun
schonberg
et
al
mechan
viral
infect
lead
autoimmun
respons
well
understood
howev
two
possibl
mechan
relev
present
review
autoantibodi
appear
follow
viral
infect
may
recogn
share
antigen
viral
protein
determin
surfac
target
cell
idiotypicantiidiotyp
network
describ
section
ii
c
antiidiotyp
antibodi
could
produc
recogn
viral
receptor
cell
surfac
thu
affin
autoantibodi
particular
cell
would
ident
tropism
viru
cell
test
two
hypothes
recent
perform
follow
experi
splenic
lymphocyt
adult
mice
infect
purifi
reoviru
type
particl
fuse
myeloma
cell
result
clone
screen
radioimmunoassay
abil
bind
viru
lymphocyt
brain
liver
lung
tissu
found
cours
normal
immun
respons
reoviru
autoantibodi
gener
react
normal
tissu
monoclon
antibodi
gener
identifi
share
antigen
structur
viral
determin
normal
tissu
monoclon
antibodi
appear
affin
cell
viru
put
antiidiotyp
antibodi
recogn
viral
receptor
anoth
group
experi
perform
onodera
et
shown
mice
infect
reoviru
type
develop
transient
diabet
runt
syndrom
sera
infect
mice
contain
autoantibodi
immunofluoresc
react
cytoplasm
antigen
islet
langerhan
anterior
pituitari
uninfect
mice
target
structur
viru
autoantibodi
appear
direct
insulin
growth
hormon
sinc
reoviru
type
induc
autoantibodi
growth
hormon
use
recombin
clone
possibl
show
abil
induc
autoantibodi
growth
hormon
properti
viral
hemagglutinin
onodera
et
al
progress
studi
virusreceptor
interact
occur
follow
three
area
develop
sophist
approach
quantit
eg
rigor
bind
studi
use
radiolabel
viru
high
specif
activ
qualit
eg
cell
sort
techniqu
measur
viral
interact
cell
surfac
product
monoclon
antibodi
cell
receptor
viral
compon
reagent
lead
isol
biolog
character
cru
function
domain
viru
attach
protein
techniqu
isol
singl
cell
suspens
organ
brain
approach
allow
direct
studi
viral
interact
biolog
relev
cell
comparison
viralreceptor
studi
perman
cell
line
studi
util
freshli
isol
cell
import
sinc
increas
evid
differ
structur
might
serv
receptor
site
viru
cell
differ
origin
role
receptor
determin
vivo
affin
certain
nonenvelop
virus
specif
cell
type
thu
determin
viral
pathogen
well
establish
must
emphas
howev
cell
permiss
viru
mere
cell
surfac
receptor
viru
bind
final
although
addit
studi
need
receptor
may
play
less
import
role
pathogen
envelop
virus
nonenvelop
virus
